. (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study. Eur Heart J Cardiovasc Pharmacother. http://doi.org/10.1093/ehjcvp/pvae022
UK data driving real-world evidence